• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, May 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Rewrite HDAC11 deficiency improves muscle function and regeneration during ageing this news headline for the science magazine post

Bioengineer by Bioengineer
May 6, 2025
in Cancer
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Badalona Neuromuscular Research Group (GRENBA) at Germans Trias i Pujol Research Institute (IGTP)

Badalona Neuromuscular Research Group (GRENBA) at Germans Trias i Pujol Research Institute (IGTP)

image: 

Badalona Neuromuscular Research Group (GRENBA) at Germans Trias i Pujol Research Institute (IGTP) 

view more 

Credit: IGTP

A new study led by the Badalona Neuromuscular Research Group (GRENBA) at the Germans Trias i Pujol Research Institute (IGTP) has identified the HDAC11 protein, an enzyme involved in cellular regulation, as a new potential therapeutic target for the treatment of sarcopenia. Published in the journal GeroScience, the study shows that HDAC11 deficiency in aged murine models reduces muscle mass loss, promotes muscle regeneration following injury and improves overall muscle function.

Sarcopenia, the progressive loss of muscle mass and function associated with ageing, negatively impacts the quality of life of the elderly population. The study demonstrates that the absence of HDAC11 reduces muscle atrophy, preserves the muscle stem cell reservoir, decreases alterations in neuromuscular junctions and promotes muscle regeneration. Furthermore, at the metabolic level, HDAC11-deficient muscles exhibit improved fatty acid oxidation and a more favourable lipid composition.

“Currently, the global population is progressively ageing, with estimates suggesting that nearly a quarter of the world’s population will be over 65 years old by 2050, which will have a significant social and economic impact,” explains Dr Mònica Suelves, principal investigator of the study, together with PhD student Renato Odria. “Maintaining muscle mass and function is key to ensuring a good quality of life during ageing, yet available treatments to prevent or reverse sarcopenia remain very limited. Studies like ours help to better understand the biological mechanisms of age-related muscle loss and propose new therapeutic strategies to support healthy ageing.”

Research in geroscience, an emerging field that investigates the biological mechanisms of ageing and its associated diseases, enables the identification of molecular factors that either accelerate or slow down ageing. “Our results show for the first time that HDAC11 can be considered a gerogene, a gene that promotes ageing, and we propose it as a new therapeutic target to reduce sarcopenia,” adds Dr Suelves.

The findings suggest that the selective inhibition of HDAC11, for which specific compounds have already been developed, could represent a new strategy to slow down age-related muscular decline and promote healthier ageing.

Journal

GeroScience

DOI

10.1007/s11357-025-01611-y

Method of Research

Experimental study

Subject of Research

Animals

Article Title

HDAC11 deficiency regulates age-related muscle decline and sarcopenia

Article Publication Date

12-Apr-2025

COI Statement

The authors declare that they have no competing interest.

Media Contact

Tamara Gutiérrez

Germans Trias i Pujol Research Institute

[email protected]

Office: 93 554 3054

Journal
GeroScience
DOI
10.1007/s11357-025-01611-y

Journal

GeroScience

DOI

10.1007/s11357-025-01611-y

Method of Research

Experimental study

Subject of Research

Animals

Article Title

HDAC11 deficiency regulates age-related muscle decline and sarcopenia

Article Publication Date

12-Apr-2025

COI Statement

The authors declare that they have no competing interest.

Keywords
/Health and medicine/Diseases and disorders/Cancer

/Health and medicine/Diseases and disorders/Gastrointestinal disorders/Inflammatory bowel diseases/Colitis/Ulcerative colitis

/Health and medicine/Clinical medicine/Translational medicine

/Health and medicine/Diseases and disorders/Immune disorders/Inflammatory disorders

bu içeriği en az 2000 kelime olacak şekilde ve alt başlıklar ve madde içermiyecek şekilde ünlü bir science magazine için İngilizce olarak yeniden yaz. Teknik açıklamalar içersin ve viral olacak şekilde İngilizce yaz. Haber dışında başka bir şey içermesin. Haber içerisinde en az 12 paragraf ve her bir paragrafta da en az 50 kelime olsun. Cevapta sadece haber olsun. Ayrıca haberi yazdıktan sonra içerikten yararlanarak aşağıdaki başlıkların bilgisi var ise haberin altında doldur. Eğer yoksa bilgisi ilgili kısmı yazma.:
Subject of Research:
Article Title:
News Publication Date:
Web References:
References:
Image Credits:

Keywords

Tags: ageing and muscle functionBadalona Neuromuscular Research Groupcellular regulation and muscle healthGeroScience journal findingsHDAC11 deficiency and muscle regenerationimplications of HDAC11 in muscle healthimproving muscle function during ageingmurine models in sarcopenia researchmuscle injury recovery in aged modelspotential treatments for age-related muscle declinestudy on muscle mass losstherapeutic target for sarcopenia

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Revised Opioid Prescribing Standards Transformed BC Practices—But Challenges Remain

May 12, 2025
blank

GLP-1 Receptor Agonists Demonstrate Anti-Cancer Effects Independent of Weight Loss

May 11, 2025

Unsupervised Learning Reveals Liver Cancer Immune Profiles

May 10, 2025

Gut Microbiota Pathways Influence CSAG1 in Chondrosarcoma

May 10, 2025

POPULAR NEWS

  • blank

    Volatile-Rich Cap Found Above Yellowstone Magma

    664 shares
    Share 265 Tweet 166
  • Natural Supplement Shows Potential to Slow Biological Aging and Enhance Muscle Strength

    87 shares
    Share 35 Tweet 22
  • The Rise of Eukaryotic Cells: An Evolutionary Algorithm Spurs a Major Biological Transition

    67 shares
    Share 27 Tweet 17
  • Analysis of Research Grant Terminations at the National Institutes of Health

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Extended Reality Boccia Demonstrates Promising Rehabilitation Benefits

Capturing Vibrational Sum-Frequency Signals from Molecules Trapped in Nanoscale Gaps via Tightly Confined Optical Near-Fields

Experts Advocate for AI as a Catalyst in Preserving Marginalized Cultures

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.